SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-21-059160
Filing Date
2021-04-30
Accepted
2021-04-30 17:01:17
Documents
3
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm211024d4_10ka.htm 10-K/A 348081
2 EXHIBIT 31.1 tm211024d4_ex31-1.htm EX-31.1 3422
3 EXHIBIT 31.2 tm211024d4_ex31-2.htm EX-31.2 3310
  Complete submission text file 0001104659-21-059160.txt   355991
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36020 | Film No.: 21879328
SIC: 2834 Pharmaceutical Preparations